Capitainer Announces Strategic Appointments to Board of Directors
Capitainer announces the appointments of Louise Warme and Andreas Lindblom to its board of directors. These appointments come at a strategic moment in Capitainer’s growth trajectory and underscore the company’s commitment to leadership in the diagnostics industry.
Capitainer is entering a significant commercialization phase, with an emphasis on strengthening sales and accelerating growth. The recent composition of the new board is tailored to support Capitainer in this direction, ensuring that the company is well-equipped to navigate this phase successfully and enhance its standing in the diagnostics market.
Louise Warme, Head of We Venture Capital (the venture capital arm of the Werfen Group), joins the Capitainer board with over ten years of experience in venture capital and life science investments along experience from 17 board engagements. With a strong foundation as a medical doctor and researcher, she has showcased her leadership as the founding CEO of a medtech startup. Louise Warme currently serves as a director on the board of Axithra and as an observer on the boards of Deepull and Zetta Genomics. She is deeply committed to advancing clinical innovations, a dedication evidenced by her holding a Clinical Innovations Fellowship at the Karolinska Institutet & Royal Institute of Technology in Stockholm, Sweden.
Andreas Lindblom, Managing Partner at Sciety, brings to the board over 25 years of experience as an experienced entrepreneur with a focus on healthcare, finance, and technology. Andreas Lindblom co-founded the investment company Sciety, driven by his passion for promoting change and growth within these sectors. His unique educational background, with a degree in Physiotherapy from Karolinska Institutet and a Master’s degree in Applied Physics from Stockholm University, underpins his solid understanding of both healthcare and technology. His entrepreneurial spirit and dedication to the Nordic life science ecosystem underscore his commitment to making a meaningful impact in the industry.
The appointment of Louise Warme and Andreas Lindblom to Capitainer's board marks a strategic move, enhancing the company's ability to navigate the diagnostics market effectively. Their collective experience and insights will be instrumental in guiding Capitainer's strategic directions and reinforcing its position as a market leader.
Christopher Aulin, CEO of Capitainer, expresses his enthusiasm for the new members: “We are very happy to welcome Louise and Andreas to our board. Their backgrounds and proven track records in healthcare, technology, and strategic investments will be instrumental in guiding Capitainer through our next phase of growth. The expertise they bring is a testament to their individual accomplishments and aligns perfectly with our mission to revolutionize the diagnostics industry through innovation and leadership.”
For more information, please contact:
Christopher Aulin, CEO
Phone: +46 (0)708 977577
Email: christopher.aulin@capitainer.com
About Capitainer
Capitainer AB is a Swedish MedTech company that develops and sells patient-centric solutions for self-sampling of blood, plasma, and urine. Founded in 2016, Capitainer has developed unique technologies for collecting and drying exact volumes of fluid within easy-to-use sampling cards. These cards may be sent as standard post to relevant testing laboratories, thus bypassing the need for cold chain logistics and specialised packaging. Capitainer’s products are market-leading with respect to precision and accuracy, with demonstrated equal performance to established pipetting methods. The products are applicable within several market segments, including but not limited to, clinical biomarkers, therapeutic drug monitoring, genomics, drug abuse and doping testing, and R&D and clinical studies.
Tags:
